Scarica l'app Stockscreener
10.33
7.05%
0.68
Dopo l'orario di chiusura:
10.13
-0.20
-1.94%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ALGS Giù?
Forum
Previsione
Precedente Chiudi:
$9.65
Aprire:
$9.65
Volume 24 ore:
88,759
Relative Volume:
1.07
Capitalizzazione di mercato:
$63.57M
Reddito:
$7.97M
Utile/perdita netta:
$-75.74M
Rapporto P/E:
-0.4254
EPS:
-24.2853
Flusso di cassa netto:
$-85.33M
1 W Prestazione:
+10.84%
1M Prestazione:
-4.17%
6M Prestazione:
+25.36%
1 anno Prestazione:
-73.09%
Intervallo 1D:
$9.61
$10.49
Intervallo di 1 settimana:
$8.25
$10.49
Portata 52W:
$3.76
$37.12
Aligos Therapeutics Inc Stock (ALGS) Company Profile
Nome
Aligos Therapeutics Inc
Settore
Industria
Telefono
(800) 466-6059
Indirizzo
ONE CORPORATE DR., 2ND FLOOR, SOUTH SAN FRANCISCO
Confronta ALGS con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ALGS
Aligos Therapeutics Inc
|
10.33 | 59.38M | 7.97M | -75.74M | -85.33M | -24.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Aligos Therapeutics Inc Stock (ALGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-18 | Ripresa | H.C. Wainwright | Buy |
| 2024-08-19 | Iniziato | H.C. Wainwright | Buy |
| 2023-01-06 | Aggiornamento | Jefferies | Hold → Buy |
| 2023-01-06 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-03-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-01-07 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-01-06 | Downgrade | Jefferies | Buy → Hold |
| 2021-09-09 | Iniziato | SVB Leerink | Outperform |
| 2021-05-17 | Ripresa | Piper Sandler | Overweight |
| 2020-11-10 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Iniziato | JP Morgan | Overweight |
| 2020-11-10 | Iniziato | Jefferies | Buy |
| 2020-11-10 | Iniziato | Piper Sandler | Overweight |
Mostra tutto
Aligos Therapeutics Inc Borsa (ALGS) Ultime notizie
Why Aligos Therapeutics Inc. stock could be next big winnerPortfolio Return Summary & Step-by-Step Trade Execution Guides - ulpravda.ru
Why analysts upgrade Aligos Therapeutics Inc. stock2025 Market Trends & Community Consensus Trade Signals - ulpravda.ru
How resilient is Aligos Therapeutics Inc. stock in market downturnsJuly 2025 Rallies & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Why analysts remain bullish on Aligos Therapeutics Inc. stockJuly 2025 Movers & Daily Volume Surge Trade Alerts - ulpravda.ru
Trend Recap: Does Aligos Therapeutics Inc. stock trade at a discount to peers2025 Price Action Summary & Daily Stock Trend Watchlist - ulpravda.ru
Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics - The Manila Times
UBS Initiates Coverage of Aligos Therapeutics (ALGS) with Buy Recommendation - Nasdaq
UBS Initiates Coverage on ALGS with a Buy Rating and $20 PT | AL - GuruFocus
Here's Why Aligos Therapeutics (NASDAQ:ALGS) Must Use Its Cash Wisely - Yahoo Finance
Aligos Therapeutics stock initiated with Buy rating at UBS on liver disease pipeline - Investing.com
(ALGS) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Is Aligos Therapeutics Inc a good long term investmentValue Traps to Avoid & Diversify Intelligently to Avoid Big Hits - earlytimes.in
Head to Head Review: Xilio Therapeutics (NASDAQ:XLO) and Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Aligos Therapeutics Inc 5WK0 Stock Analysis and ForecastEquity Performance Review & Small Investment Portfolio Tips - earlytimes.in
Aug PreEarnings: How Aligos Therapeutics Inc 5WK0 stock reacts to fiscal policies2025 Pullback Review & Low Drawdown Momentum Trade Ideas - moha.gov.vn
Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5% – Time to Sell? - Defense World
Aligos Therapeutics (NASDAQ:ALGS) Stock Price Down 4.5%Time to Sell? - MarketBeat
Aligos Therapeutics secures $105 million in private placement - MSN
Technical Reactions to ALGS Trends in Macro Strategies - Stock Traders Daily
Can Aligos Therapeutics Stock Recover If Markets Fall? - Trefis
Analyst Calls: Why Aligos Therapeutics Inc. stock is rated strong buyJuly 2025 Decliners & Community Consensus Trade Signals - DonanımHaber
Why Aligos Therapeutics Inc. stock is a must watch in 20252025 Trade Ideas & Free Fast Gain Swing Trade Alerts - DonanımHaber
Aligos Therapeutics Earnings Notes - Trefis
Gainers Report: Does Aligos Therapeutics Inc stock trade at a discount to peers2025 Technical Overview & Expert Approved Momentum Ideas - moha.gov.vn
Hepatitis B Virus Infection Clinical Trial Pipeline Accelerates as 80+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Globe and Mail
(ALGS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
What analysts say about Aligos Therapeutics Inc stockPrice-to-Earnings Ratio Insights & Minimal Investment Portfolio - earlytimes.in
Aligos Therapeutics, Inc. (ALGS) Fundamental Analysis - Meyka
Aligos Therapeutics (ALGS) Issues Stock Options to New Employees - GuruFocus
Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Globe and Mail
Aligos reports synergistic weight loss effect with THR-β agonist By Investing.com - Investing.com South Africa
Aligos reports synergistic weight loss effect with THR-β agonist - Investing.com
Aligos Therapeutics (ALGS) Unveils Promising Data at HEP-DART 20 - GuruFocus
Aligos Therapeutics Highlights Positive Data on Pevifoscorvir Sodium and ALG-055009 at HEP-DART 2025 Meeting - Quiver Quantitative
Aligos Therapeutics, Inc. Presents Positive Data at HEP-DART 2025 - marketscreener.com
Aligos Therapeutics (NASDAQ:ALGS) Will Have To Spend Its Cash Wisely - Sahm
Contrasting Neurogene (NASDAQ:NGNE) & Aligos Therapeutics (NASDAQ:ALGS) - Defense World
Reviewing Aligos Therapeutics (NASDAQ:ALGS) and ANI Pharmaceuticals (NASDAQ:ANIP) - Defense World
Why Aligos Therapeutics Inc. (5WK0) stock could be next leaderWeekly Trend Summary & Safe Capital Growth Plans - Newser
How supply shortages influence Aligos Therapeutics Inc. (5WK0) stockJuly 2025 Gainers & Low Drawdown Investment Strategies - Newser
What dividend safety rating applies to Aligos Therapeutics Inc. (5WK0) stockGold Moves & AI Driven Stock Movement Reports - Newser
Can Aligos Therapeutics Inc. (5WK0) stock sustain margin levelsJuly 2025 Highlights & Verified Entry Point Signals - Newser
What is the fair value estimate for Aligos Therapeutics Inc. (5WK0) stock in 2025Gap Down & Long-Term Capital Growth Strategies - Newser
Is Aligos Therapeutics Inc. (5WK0) stock resilient in recession scenariosJuly 2025 Drop Watch & Comprehensive Market Scan Insights - Newser
Why Aligos Therapeutics Inc. stock is a value investor pickJuly 2025 Closing Moves & Consistent Income Trade Ideas - Newser
Can Aligos Therapeutics Inc. stock beat market expectations this quarter2025 EndofYear Setup & Accurate Entry and Exit Point Alerts - Newser
Will Aligos Therapeutics Inc. (5WK0) stock split increase liquidityMarket Movers & Free Real-Time Volume Trigger Notifications - Newser
Responsive Playbooks and the ALGS Inflection - news.stocktradersdaily.com
Sio Capital Management LLC Increases Stock Position in Aligos Therapeutics, Inc. $ALGS - MarketBeat
Aligos Therapeutics Inc Azioni (ALGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.80%
4.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):